News

Just a summary of all the news articles that we could source from different places. A good way to make an investment decision is also to look at how actively the company is engaging with news sources to keep them in the news. In this day and age its critical to have a media presence.

Please consider a small donation if you think this website provides you with relevant information  

   
Date Title Source
2024-03-06 9:54:19 am ADAP Stock Earnings: Adaptimmune Therapeutics Misses EPS, Misses Revenue for Q4 2023 InvestorPlace
2024-03-06 4:0:0 am Adaptimmune Reports Q4/Full Year 2023 Financial Results and Business Updates Newsfile
2024-02-27 5:0:0 am Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company's Sarcoma Franchise Newsfile
2024-02-21 1:0:0 pm Adaptimmune to Report Q4 and Full Year 2023 Financial and Business Updates on Wednesday, March 6, 2024 Newsfile
2024-02-16 12:57:34 am 15 Top Performing European Stocks So Far in 2024 Insider Monkey
2024-02-13 3:15:8 pm Adaptimmune Therapeutics PLC (ADAP) Stock Moves -1.24%: What You Should Know Zacks
2024-01-31 1:44:0 pm Adaptimmune Announces U.S. FDA Acceptance of Biologics License Application for Afami-cel for the Treatment of Advanced Synovial Sarcoma with Priority Review Newsfile
2024-01-30 10:2:49 am Baillie Gifford Increases Stake in Adaptimmune Therapeutics PLC GuruFocus.com
2024-01-17 2:23:50 am Adaptimmune Therapeutics (NASDAQ:ADAP shareholders incur further losses as stock declines 22% this week, taking three-year losses to 88% Simply Wall St.
   

Please consider a small donation if you think this website provides you with relevant information